Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections - American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn (Pediatrics, 2003)